Author

A. Farzadfard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Abelein· 1 shared D. E. Otzen· 1 shared H. Biverstal· 1 shared H. Klute· 1 shared J. Johansson· 1 shared J. Nielsen· 1 shared J. S. Nowak· 1 shared L. Adam· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

A. Abelein

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS

L. Adam, R. Kumar, L. E. Arroyo-Garcia, W. H. Molenkamp, J. S. Nowak, H. Klute, A. Farzadfard, R. Alkenayeh, J. Nielsen, H. Biverstal, D. E. Otzen, J. Johansson, A. Abelein

This study shows that the Bri2 BRICHOS domain inhibits α-synuclein oligomer formation and toxicity by suppressing secondary nucleation and binding oligomers, suggesting its potential as a therapeutic target for Parkinson's disease.

bioRxiv · Dec 7, 2023Biophysics